Nektar Therapeutics reported $19K in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 71K 0
ALKERMES ALKS:US USD 1.69M 1000
Amgen AMGN:US USD 32.37B 1.03B
Astrazeneca AZN:US USD 387M 0
Baxter International BAX:US USD 683M 0
Biogen BIIB:US USD 100K 0
Bluebird Bio BLUE:US USD 829K 94K
Bristol Myers Squibb BMY:US USD 292M 0
Cara Therapeutics CARA:US USD 53K 0
Eisai 4523:JP JPY 44.99B 0
Eli Lilly And LLY:US USD 594.1M 0
Esperion Therapeutics ESPR:US USD 72K 7K
Exelixis EXEL:US USD 323K 1000
GlaxoSmithKline GSK:LN GBP 1.35B 0
Halozyme Therapeutics HALO:US USD 135K 3K
Immunogen IMGN:US USD 2.21M 2K
IONIS PHARMACEUT IONS:US USD 142K 0
Ironwood Pharmaceuticals IRWD:US USD 153K 0
Karyopharm Therapeutics KPTI:US USD 8K 0
Macrogenics MGNX:US USD 615K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 878.25M 11.75M
Sarepta Therapeutics SRPT:US USD 9K 0
Seattle Genetics SGEN:US USD 185K 1000
Takeda 4502:JP JPY 1.68T 53M
Teva Pharmaceutical TEVA:IT USD 20.31B 387.03M
Xencor XNCR:US USD 598K 0
YTE INCY:US USD 222K 0